QU BIOLOGICS INC.
Qu Biologics is developing a platform of new immunotherapeutic treatments. Our Site Specific Immunomodulators (SSIs) aim to activate the body’s immune system to reverse the chronic inflammation underlying many conditions including cancer and immune-related diseases, such as Crohn’s disease. More than 270 patients with advanced cancer and moderate-to-severe immune-related disease have been treated with Qu Biologics’ SSIs through a compassionate use program. The preliminary findings sug... gest some promising outcomes which support further research in controlled clinical trials. Currently, we are recruiting for a Phase 1/2 clinical trial in Crohn’s disease. More information on this Crohn’s disease research trial can be found at www.qucrohnstrial.com. Qu Biologics’ goal is to develop SSIs to improve the survival and quality of life of millions of people fighting cancer and the quality of life of people living with debilitating immune-related diseases such as Crohn’s disease, ulcerative colitis and rheumatoid arthritis. - See more at: http://www.qubiologics.com/#sthash.tKIA4N2Z.dpuf
QU BIOLOGICS INC.
Industry:
Biotechnology Health Care Medical
Founded:
2007-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.qubiologics.com
Total Employee:
11+
Status:
Active
Contact:
(604) 734-1450
Email Addresses:
[email protected]
Total Funding:
22.58 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics WordPress Content Delivery Network Google Universal Analytics Wordpress Plugins Sitelinks Search Box Euro
Similar Organizations
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Employees Featured
Founder
Investors List
Neue Fund
Neue Fund investment in Venture Round - Qu Biologics Inc.
Official Site Inspections
http://www.qubiologics.com
- Host name: 162.223.226.41
- IP address: 162.223.226.41
- Location: Vancouver Canada
- Latitude: 49.245
- Longitude: -123.1337
- Timezone: America/Vancouver
- Postal: V6H
